Hepatocyte growth factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma

Journal of Urology

Volumn 171, Issue 2 I, 2004, Pages 890-896

  Yamauchi, Masamichi ^b   Kataoka, Hiroaki ^a   Itoh, Hiroshi ^b   Seguchi, Tomoko ^b   Hasui, Yoshihiro ^b   Osada, Yukio ^b  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NONE

Author keywords

Carcinoma, renal cell; Hepatocyte growth factor activator inhibitor 2; Hepatocyte growth factor activator inhibitor 1; Kidney

Indexed keywords

GROWTH FACTOR; HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR 1; HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR 2; MESSENGER RNA; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUBULE EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0347129545     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000092861.21122.d2     Document Type: Article

References (20)

1. Matsumoto, K. and Nakamura, T.: Renotropic role and therapeutic potential of HGF in the kidney. Nephrol Dial Transplant, suppl., 17: 59, 2002
2. Kataoka, H., Miyata, S., Uchinokura, S. and Itoh, H.: Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor. Cancer Metastasis Rev, 22: 223, 2003
3. Miyazawa, K., Shimomura, T., Kitamura, A., Kondo, J., Morimoto, Y. and Kitamura, N.: Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. Structural similarity for the protease precursor to blood coagulation factor XII. J Biol Chem, 268: 10024, 1993
4. Miyazawa, K., Shimomura, T. and Kitamura, N.: Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J Biol Chem, 271: 3615, 1996
5. van Adelsberg, J. S., Sehgal, S., Kukes, A., Brady, C., Barasch, J., Yang, J. et al: Activation of hepatocyte growth factor (HGF) by endogenous HGF activator is required for metanephric kidney morphogenesis in vitro. J Biol Chem, 276: 15099, 2001
6. Shimomura, T., Denda, K., Kitamura, A., Kawaguchi, T., Kito, M., Kondo, J. et al: Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J Biol Chem, 272: 6370, 1997
7. Kawaguchi, T., Qin, L., Shimomura, T., Kondo, J., Matsumoto, K., Denda, K. and Kitamura, N.: Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. J Biol Chem, 272: 27558, 1997
8. Kataoka, H., Shimomura, T., Kawaguchi, T., Hamasuna, R., Itoh, H., Kitamura, N. et al: Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment. J Biol Chem, 275: 40453, 2000
9. Lin, C. Y., Anders, J., Johnson, M. and Dickson, R. B.: Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem, 274: 18237, 1999
10. Takeuchi, T., Harris, J. L., Huang, W., Yan, K. W., Coughlin, S. R. and Craik, C. S.: Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem, 275: 26333, 2000
11. Delaria, K. A., Muller, D. K., Marlor, C. W., Brown, J. E., Das, R. C., Roczniak, S. O. et al: Characterization of placental bikunin, a novel human serine protease inhibitor. J Biol Chem, 272: 12209, 1997
12. Mitchell, K. J., Pinson, K. I., Kelly, O. G., Brennan, J., Zupicich, J., Scherz, P. et al: Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat Genet, 28: 241, 2001
13. Motzer, R. J., Bander, N. H. and Nanus, D. M.: Renal-cell carcinoma. N Engl J Med, 335: 865, 1996
14. Schmidt, L., Duh, F. M., Chen, F., Kishida, T., Glenn, G., Choyke, P. et al: Germline and somatic mutations in the tyrosine kinase domain of the MET protooncogene in papillary renal carcinomas. Nat Genet, 16: 68, 1997
15. Pisters, L. L., El-Naggar, A. K., Luo, W., Malpica, A. and Lin, S.-H.: c-met proto-oncogene expression in benign and malignant human renal tissues. J Urol, 158: 724, 1997
16. Horie, S., Aruga, S., Kawamata, H., Okui, N., Kakizoe, T. and Kitamura, T.: Biological role of HGF/MET pathway in renal cell carcinoma. J Urol, 161: 990, 1999
17. Kataoka, H., Suganuma, T., Shimomura, T., Itoh, H., Kitamura, N., Nabeshima, K. et al: Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues. J Histochem Cytochem, 47: 673, 1999
18. Kataoka, H., Hamasuna, R., Itoh, H., Kitamura, N. and Koono, M.: Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma. Cancer Res, 60: 6148, 2000
19. Shimomura, T., Kondo, J., Ochiai, M., Naka, D., Miyazawa, K., Morimoto, Y. et al: Activation of the zymogen of hepatocyte growth factor activator by thrombin. J Biol Chem, 268: 22927, 1993
20. Lee, S. L., Dickson, R. B. and Lin, C. Y.: Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase and epithelial membrane serine protease. J Biol Chem, 275: 36720, 2000